COMMUNIQUÉS West-GlobeNewswire

Medibio Announces Next Tranche of Corporate Health Contracts
10/05/2018
Global mining, engineering, construction and sporting organizations are joining the Check-in SYDNEY, Australia and MINNEAPOLIS, May 09, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company )(ASX:MEB) (OTCQB: [...]
Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
10/05/2018
-Aquinox to Receive $25M in Upfront Payment, Potentially Over $100M in Additional Milestone Payments and Royalties- -Astellas to Obtain Development and Commercialization Rights to Rosiptor, Aquinox’s Lead Drug Candidate [...]
Integra LifeSciences Prices Public Offering of Common Stock
10/05/2018
PLAINSBORO, N.J., May 09, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, today announced that it has priced its previously announced [...]
REVA to Hold Annual General Meeting of Stockholders
10/05/2018
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) will hold its 2018 Annual General Meeting of Stockholders (the “AGM”) on Wednesday, May 16, 2018 at 4:00 p.m. US PDT ( [...]
MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma
10/05/2018
LA JOLLA, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]
Catalyst Biosciences to Host Key Opinion Leader Meeting on Novel Treatments for Hemophilia B and Hemophilia with Inhibitors
10/05/2018
SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), today announced that it will host a Key Opinion Leader (KOL) breakfast on the topic of novel treatments for [...]
Atrion Reports First Quarter Results
09/05/2018
ALLEN, Texas, May 09, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq: ATRI ) today announced revenues for the quarter ended March 31, 2018 were $39.4 million compared with $38.5 million in the same period in 2017. [...]
SELLAS Life Sciences Receives FDA Orphan Drug Designation for Galinpepimut-S (GPS) for Treatment of Multiple Myeloma (MM)
09/05/2018
NEW YORK, May 09, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc. (Nasdaq: SLS ) (“SELLAS”), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]
Profound Medical Corp. Announces Chinese Food and Drug Administration Approval for Sonalleve®
09/05/2018
TORONTO, May 09, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Otonomy Reports First Quarter 2018 Financial Results and Provides Corporate Update
09/05/2018
Conference call and webcast today at 4:30 p.m. EDT SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC ), a biopharmaceutical company dedicated to the development of innovative therapeutics for [...]
BeiGene Reports First Quarter 2018 Financial Results
09/05/2018
CAMBRIDGE, Mass. and BEIJING, China, May 09, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted [...]
Integra LifeSciences Announces Proposed Public Offering of Common Stock
09/05/2018
PLAINSBORO, N.J., May 09, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, today announced that it intends to offer, subject to market [...]
Catalyst Pharmaceuticals Announces First Quarter 2018 Financial Results and Provides Corporate Update
09/05/2018
--Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow CORAL GABLES, Fla., May 09, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX ), a biopharmaceutical company focused on developing [...]
Asterias Biotherapeutics Reports First Quarter Financial Results and Recent Development Progress
09/05/2018
- AST-VAC2 Immunotherapy Program Prepares to Enter Clinic in Second Quarter of 2018 – - Conference Call and Webcast Today, May 9, at 5:00 p.m. ET – FREMONT, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Asterias [...]
Chembio Diagnostics Reports First Quarter 2018 Financial Results
09/05/2018
MEDFORD, N.Y., May 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today reported financial results for the first [...]
Menlo Therapeutics Reports First Quarter 2018 Financial Results
09/05/2018
REDWOOD CITY, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus associated [...]
resTORbio to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
09/05/2018
BOSTON, May 09, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]
Dova Pharmaceuticals Reports First Quarter 2018 Operating and Financial Results
09/05/2018
PDUFA date for avatrombopag of May 21, 2018 Conference call scheduled for 4:30 p.m. ET today DURHAM, N.C., May 09, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ), a pharmaceutical company focused on [...]
miRagen Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
09/05/2018
MRG-110 advanced into clinical development with the initiation of two Phase 1 clinical trials in collaboration with Servier Preclinical data released in two separate ophthalmology programs targeting microRNA-29 and the [...]

Pages